Literature DB >> 1812767

AIDS drugs & the pharmaceutical industry: a need for reform.

M T Griffin1.   

Abstract

The pharmaceutical industry has long enjoyed substantial profits despite increased requirements for drug approval and various attempts to regulate the industry. Drug companies have avoided effective regulation by blaming high prices on the costs of research and development. The search for drugs effective in combatting HIV and AIDS related illnesses has provided a stark background on which to view the actions and justifications of drug companies. Despite increased cooperation between government and the drug industry and expedited approval of several useful drugs, these drugs are still prohibitively expensive. This Article explores the history and economics of the drug industry and proposes a system of national price regulation for all drugs.

Entities:  

Keywords:  Health Care and Public Health; Legal Approach

Mesh:

Year:  1991        PMID: 1812767

Source DB:  PubMed          Journal:  Am J Law Med        ISSN: 0098-8588


  3 in total

1.  Impact of consumer fees on drug utilisation.

Authors:  D G Smith; D M Kirking
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

2.  Scenario analysis of the future of medicines.

Authors:  H Leufkens; F Haaijer-Ruskamp; A Bakker; G Dukes
Journal:  BMJ       Date:  1994-10-29

3.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.